![SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8% SUSPENSION [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/87395273-37fa-7cef-e053-2991aa0a54c6/8170-6 end.jpg)
![SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8% SUSPENSION [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/87395273-37fa-7cef-e053-2991aa0a54c6/8170-6 front.jpg)
![SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8% SUSPENSION [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/87395273-37fa-7cef-e053-2991aa0a54c6/8170-6 middle.jpg)
- Directions for use
- Sincerus Florida. Adverse Reactions
- Active, Inactive
- NDC 72934-8170-6 SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8% Suspension 120 gm
-
INGREDIENTS AND APPEARANCE
SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8%
salicylic acid 2% /sodium sulfacetamide monohydrate 8% suspensionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-8170 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SULFACETAMIDE SODIUM (UNII: 4NRT660KJQ) (SULFACETAMIDE - UNII:4965G3J0F5) SULFACETAMIDE SODIUM 8 g in 100 g SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 2 g in 100 g Product Characteristics Color yellow Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-8170-6 120 g in 1 CYLINDER; Type 0: Not a Combination Product 05/01/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/01/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-8170)
